| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| GUIDELINES-FOR-PRE-P..> | 2021-11-02 06:21 | 168K | ||
| GUIDELINES-FOR-PRE-R..> | 2021-11-02 06:08 | 134K | ||
| CLINICAL-TRIAL-APPLI..> | 2021-10-25 13:59 | 367K | ||
| GUIDELINES-FOR-CLINI..> | 2021-10-25 13:59 | 113K | ||
| GUIDELINES-FOR-CLINI..> | 2021-10-25 13:58 | 180K | ||
| GUIDELINES-FOR-CLINI..> | 2021-10-25 13:56 | 704K | ||
| GUIDELINES-FOR-CLINI..> | 2021-10-25 13:56 | 264K | ||
| GUIDELINES-FOR-GSP-G..> | 2021-10-25 13:55 | 123K | ||
| GUIDELINES-FOR-IMPOR..> | 2021-10-25 13:54 | 141K | ||
| GUIDELINES-FOR-INSPE..> | 2021-10-25 13:54 | 98K | ||
| GUIDELINES-FOR-LABEL..> | 2021-10-25 13:53 | 170K | ||
| GUIDELINES-for-PRODU..> | 2021-10-25 13:52 | 129K | ||
| GUIDELINES-FOR-PRODU..> | 2021-10-25 13:51 | 157K | ||
| NAFDAC-GMP-GUIDELINE..> | 2021-10-25 13:51 | 197K | ||
| NAFDAC-GOOD-COLD-CHA..> | 2021-10-25 13:51 | 141K | ||